16 
Dr. Walters adjourned the meeting of the subworking group at 12:10 p.m. 
r Executive Secretary's Note: The version of the "Points to Consider in the 
Design and Submission of Human Scmatic-Cell Gene Therapy Protocols" developed 
at this meeting is Attachment VI.] 
Respectfully s limit ted , 
Ct-tl. /~fi 
*£ l. V : 
Elizaubeth A. 
Rapporteur 
Milewski, 
UL_ 
Fh.D. 
Date 
[ 16 ] 
